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Abstract. – OBJECTIVE: The pathogenesis of
polycystic ovary syndrome (PCOS), a common
endocrine disease and metabolic disturbance, is
still unknown. The aim of the study was to inves-
tigate whether patients with PCOS display in-
creased expression of inflammatory markers in
adipose tissue.
PATIENTS AND METHODS: Two groups of
women were investigated, those diagnosed with
PCOS (n = 8) and age and BMI-matched normal
women (n = 12). Their age was between 20-45
years and all subjects were apparently healthy
and did not take any medications. Adipose tis-
sue levels of mRNA of inflammatory markers
were determined by use of real-time PCR.
RESULTS: There were no differences between
obese patients and obese PCOS in levels of
adipocytokines.
CONCLUSIONS: There were no effects of
PCOS on the expression of any of the adipocy-
tokines genes measured in subcutaneous adi-
pose tissue.
Key Words:
Polycystic ovary syndrome, Insulin resistance, In-
flammation.
Introduction
The pathogenesis of polycystic ovary syn-
drome (PCOS), a common endocrine disease and
metabolic disturbance, is still unknown. A link
between disturbed adipokines secretions and type
2 diabetes in PCOS has previously been shown,
and several studies indicate that the incidence of
insulin resistance in PCOS women is related to
the levels of adipokines in the blood1. There is in-
creasing evidence that the expression of some
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genes associated with insulin resistance could be
affected by high levels of testosterone (T) in
PCOS2. Many studies report that dysfunction of
adipose tissue might be involved in the patho-
genesis of PCOS3,4. Patients with PCOS have
low-grade inflammation characterized by high
levels of tumor necrosis factor alpha (TNF-α)
and interlukin-6 (IL-6)5,6. Recently, studies have
focused on adipose tissue morphology in PCOS
patients and tried to discover the link between
adiponectin secreted from adipocytes and insulin
resistance7. High levels of androgens are thought
to impact on adipose tissue function and distribu-
tion in women with PCOS8. Previous researches
have suggested that the molecules released by
adipocytes, such as adiponectin, resistin, leptin,
TNF-α and IL-6, are crucial factors in the pathol-
ogy of PCOS and can be influenced by estrogens
and androgens9-12. However, some investigations
have suggested that the role of adipokines in the
pathogenesis of PCOS is more complicated1. The
effects of raised T levels in PCOS could be di-
rectly on the expression of adipokines secreted
by adipocytes, such as adiponectin and resistin,
which affect insulin resistance. These adipokines
and cytokines are stimulated by other cytokines
released by macrophages such as TNF-α and IL-
613,14. We suggested that excess testosterone in
the blood of women with PCOS alters the ex-
pression of adipocytokines involved in insulin re-
sistance in subcutaneous fat tissue. To compare
expression of adipokines that play an important
role in insulin resistance in subcutaneous fat tis-
sue from women suffering from hyperandro-
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tase buffer, Nucleotides, RNase inhibitor, MMLV
reverse transcriptase, and RNase water were
added. All of them were mixed and spined down
then incubated at room temperature for 10 min
then returned into PCR machine to incubate them
at 42°C for 60 min. All the mRNA of treated
cells was investigated by RT-PCR. All cDNA
samples were mix with SYBR Green I master
(containing HotStarTaq DNA polymerase, Quan-
tiTectSYBR Green PCR Buffer, dNTP mix and
SYBR Green I) and mixed with 1.25 µL of each
primer. The sequences of all genes investigated
are listed on Table l.
Statistical Analysis
To compare the effects of PCOS on gene ex-
pression of Inflammatory Markers in adipose tis-
sue, one-way ANOVA was performed by SPSS
21 (SPSS Inc., Chicago, IL, USA). Data were ex-
pressed as mean ± SEM and considered signifi-
cant where p < 0.05.
Results
All women with PCOS have polycystic
ovaries, and the majority also had clinical or bio-
chemical hyperandrogenism among overweight
patients with PCOS compare to normal patients.
Baseline characteristics of the study population
are shown in Table II. Both the overweight pa-
tients with PCOS and normal patients were at a
similar age. In comparison with normal patients,
patients with PCOS had increased serum concen-
trations of free androgen index, LH, and testos-
terone (p-value = 0.042, < 0.001, 0.004 respec-
tively).
Expression of almost of genes involved in in-
sulin resistance directly or indirectly such as
adiponectin, resistin, TNF-α, IL-6, Peroxisome
proliferator-activated receptor gamma (PPARg),
CCAAT-enhancer-binding proteins (C/EBP al-
pha), rantes, omentin, visfatin, MCP-1 and leptin
were done by RT-PCR in the subcutaneous adi-
pose tissue. There is no significant difference be-
tween normal patients compare with PCOS pa-
tients in all genes mentioned above. In term of
adipogenesis markers PPARg and C/EBP alpha,
both are similar in two groups. There were no
differences between obese patients with obese
PCOS in levels of adipose tissue mRNA for
adiponectin and as well as the Figure 1 shows
that a big variation between the groups in gene
Patients and Methods
Patients
Two groups of women were investigated, those
diagnosed with PCOS (n=8) and age and BMI-
matched normal women (n=12). Their age was
between 20-45 years and all subjects were appar-
ently healthy and did not take any medication.
None of the subjects was postmenopausal and
they all gave their consent to provide samples of
subcutaneous adipose tissue. Height and weight
were obtained and BMI calculated. The weight
of collected samples did vary and was dependent
on both the patients and the surgical conditions.
All samples were immediately frozen in liquid
nitrogen and stored at -80°C until total RNA iso-
lation.
Criteria Considered For Screening and
Diagnosis of Patients
This work was carried out with women of re-
productive age, with BMI between 16.5 and 36.6
kg/m2. Twenty hirsute women presenting oli-
go/amenorrheic cycles, increased levels of serum
T or free androgen index (FAI), and/or polycystic
ovaries, without other disorders causing hir-
sutism were enrolled.
Fat Biopsies
Following general anesthesia, 1.5 cm2 of su-
perficial subcutaneous of adipose tissue was ex-
cised through a 1.5 cm incision. The fat biopsies
were placed into vials and snap frozen in liquid
nitrogen and stored at -80°C until assayed.
RNA Extraction
Total RNA was extracted from subcutaneous
adipose tissue (100-150 mg) using Trizol (Invit-
rogen Corp., Carlsbad, CA, USA), followed by
tested the quality of RNA. cDNA was synthe-
sized from 500 ng of total RNA and prepare real
time poly chain reaction (RT-PCR) steps. For cD-
NA synthesis, the pellets were dried for 10 min
then RNA quality was assessed with a nanodrop
machine. The absorbance of 1.5 µL from each
sample was determined spectrophotometrically at
260 nM and 280 nM against a water blank at 260
nM. The ratio of purity of RNA was between the
absorbance at 260 and 280 nM ranged from 1.8
to 2. 100 ng/µL for each sample was calculated
by adding RNase-free water. To complete cDNA
synthesis, random primer, H2O were added and
incubated at 70°C for 5 min in PCR machine.
The following mixture MMLV reverse transcrip-

























Table I. Primer Sequences Used for RT-PCR.
Subject characteristics Normal atients (n = 12) PCOS patients (n = 8) p-value
Age(years) 34.6 (28-45) 35.7 (22-45) 0.699
Testosterone nmol/l 1.14 (0.6-1.5) 2.1 (1.4-2.9) 0.004
FSH iu/l 6.86 (4.7-10.0) 6.7 (4.5-9.6) 0.884
FAI 0.8 (0.4-1.3) 1.78 (1.0-3.0) 0.042
LH iu/l 2.4 (1.2-3.6) 14.122 (6.3-21.0) < 0.001
Table II. Clinical characteristics of women in a study of markers of adipose tissue inflammation in relation to PCOS.
expression of resistin. TNF-α and IL-6 expres-
sion did not differ between the groups and as
well as Leptin and Visfatin, whereas MCP-1 gene
expression was decreased in PCOS patient com-
pared to normal patients but not significant. In
contrast, Omentin-1 was increased 5 folds in a
normal patient, but due to a big standard error it
is not significant Figure 1.
Discussion
The aim of this study was to investigate the ef-
fect of high level of free testosterone in the blood
on insulin resistance caused by an imbalance be-
tween adipocytokines in subcutaneous fat tissue
obtained from PCOS patients and normal pa-
tients at the same BMI and age. The stimulus for
the study to compare between PCOS and normal
patients is that most of the PCOS patients have
insulin resistance which could be as a result of
hyperandrogenemia1,2,7. This report demonstrates
that the gene expression pattern of a number of
genes in abdominal superficial subcutaneous tis-
sue relating to insulin resistance and markers of
inflammation were similar in overweight women
with and without PCOS.
In terms of Adiponectin, levels of adiponectin
mRNA in SAT from the two groups are consistent
with recent scholars2,15-17 and agrees with another
work18 comparing people with high sensitivity and
low sensitivity to insulin. By contrast, Carmina et
al19 suggested that expression of adiponectin and
leptin mRNA in subcutaneous samples obtained
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Figure 1. Levels of mRNA for inflammatory substances (mean ± SD) in abdominal superficial subcutaneous adipose tissue
from obese patients with PCOS (n = 8), and obese control subjects (n = 12). Levels of mRNA are relative to the cyclophilin
gene (Cyclo), which was used to normalize data.
from PCOS patients was low compared with nor-
mal women. On the other hand, some studies ap-
peared to suggest that omental, not subcutaneous,
adipose tissue secretes adiponectin and correlates
negatively with body fat mass20,21.
Resistin levels in PCOS have been sparsely in-
vestigated, and the findings have been conflict-
ing22,23. No difference in mRNA levels of resistin
is not consistent with results produced
previously24. The results also do not agree with an-
other study16, possibly due to different fat tissue
(omental fat) being used.
Regarding TNF-α, no difference was noted be-
tween the two groups, which is consistent with 2
other studies2,25, but disagrees with another26,
who suggest that levels of TNF-alpha mRNA in
SAT are significantly higher in women with
PCOS than those in BMI-matched controls. Vari-
ous inflammatory proteins have been investigated
in women with PCOS, including IL-6 and the da-
ta is suggestive of the presence of a chronic low-
grade inflammatory state, especially in obesity,
insulin resistance and hyperandrogenism. Figure
5.1 shows that levels of IL-6 gene expression are
similar in both PCOS and normal patients. This
data is supported by previous results2. However,
the amount of IL-6 mRNA in VAT is 10 fold
more than in SAT27 and the amount of IL-6 se-
creted by VAT explants is clearly higher than that
secreted by SAT explants.
Leptin gene expression levels were the same in
both groups, but one study19 implied that expres-
sion was lower in both omental and SAT ob-
tained from PCOS women, whereas others28-30
suggested Leptin gene expression was higher in
SAT obtained from PCOS women compared to
normal patients.MCP-1 expression was also not
different between the two groups and this result
is consistent with all previous works on MCP-1
in PCOS women25,31. Visfatin gene expression
was similar between the two groups, which is
supported by previous papers2,32,33. There was no
difference in the expression of Visfatin between
visceral and SAT, and no correlation observed
between plasma Visfatin and visceral fat mass33.
Moreover, Seow et al16 investigated the expres-
sion of visfatin mRNA in omental fat tissue and
it was significantly higher in the women with
PCOS than in the controls.
The main advantage of using subcutaneous fat
is that the procedure for obtaining samples is less
invasive than for visceral fat, but we could not
determine the protein levels of the various
adipokines due to limited sample volume.
Conclusions
There were no effects of PCOS on the expres-
sion of any of the adipocytokines genes mea-
sured in SAT, despite significantly higher levels
of free testosterone in this group compared with
control women. This may be explained by the
fact that the plasma levels of free testosterone in
our PCOS population, although above the normal
range for females, was still only a tenth of the an-
drogen levels in males, and thus did not reach the
levels where they might be expected to have an
effect on gene expression. Furthermore, there
may be differences in androgen levels between
PCOS populations due to differences in BMI and
levels of insulin resistance and sex hormone-
binding globulin, which may explain some of the
discrepancies between our report and previous
studies. Moreover, we believe that a limitation of
our research may relate to the number of subjects
observed, since other studies have had higher
numbers in the two groups. Since visceral adi-
posity is thought to be the closest link to meta-
bolic risk, it is unfortunate that we had only biop-
sies from the abdominal superficial SAT depot. It
has recently been reported that the different adi-
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